Construction of a bispecific single chain antibody for recruitment of cytotoxic T cells to the tumour stroma associated antigen fibroblast activation proteinWÜEST, Thomas; MOOSMAYER, Dieter; PFIZENMAIER, Klaus et al.Journal of biotechnology. 2001, Vol 92, Num 2, pp 159-168, issn 0168-1656Article

Radioimmunotherapy of Fibroblast Activation Protein Positive Tumors by Rapidly Internalizing AntibodiesFISCHER, Eliane; CHAITANYA, Krishna; WÜEST, Thomas et al.Clinical cancer research (Print). 2012, Vol 18, Num 22, pp 6208-6218, issn 1078-0432, 11 p.Article

Tumor-specific Crosslinking of GITR as Costimulation for ImmunotherapyBURCKHART, Tanja; THIEL, Markus; NISHIKAWA, Hiroyoshi et al.Journal of immunotherapy (1997). 2010, Vol 33, Num 9, pp 925-934, issn 1524-9557, 10 p.Article

Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivativeWAJANT, Harald; MOOSMAYER, Dieter; WÜEST, Thomas et al.Oncogene (Basingstoke). 2001, Vol 20, Num 30, pp 4101-4106, issn 0950-9232Article

Targeted therapy of renal cell carcinoma: Synergistic activity of cG250-TNF and IFNgBAUER, Stefan; OOSTERWIJK-WAKKA, Jeannette C; DIVGI, Chaitanya et al.International journal of cancer (Print). 2009, Vol 125, Num 1, pp 115-123, issn 0020-7136, 9 p.Article

Human antibody derivatives against the fibroblast activation protein for tumor stroma targeting of carcinomasMERSMANN, Michael; SCHMIDT, Alexej; RIPPMANN, Jörg F et al.International journal of cancer. 2001, Vol 92, Num 2, pp 240-248, issn 0020-7136Article